Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry
about
The application of selective reaction monitoring confirms dysregulation of glycolysis in a preclinical model of schizophrenia.Mass spectrometry-based protein assays for in vitro diagnostic testing.Mass spectrometry assays of plasma biomarkers to predict radiographic progression of knee osteoarthritis.Evaluation of large scale quantitative proteomic assay development using peptide affinity-based mass spectrometry.Quantification of peptides from immunoglobulin constant and variable regions by LC-MRM MS for assessment of multiple myeloma patientsFrom lost in translation to paradise found: enabling protein biomarker method transfer by mass spectrometryPeptide immunoaffinity enrichment coupled with mass spectrometry for peptide and protein quantification.MK-801 treatment affects glycolysis in oligodendrocytes more than in astrocytes and neuronal cells: insights for schizophrenia.Relative quantification of serum proteins from pancreatic ductal adenocarcinoma patients by stable isotope dilution liquid chromatography-mass spectrometry.Testosterone replacement in hypogonadal men alters the HDL proteome but not HDL cholesterol efflux capacityAdvancing the sensitivity of selected reaction monitoring-based targeted quantitative proteomics.Large-Scale Interlaboratory Study to Develop, Analytically Validate and Apply Highly Multiplexed, Quantitative Peptide Assays to Measure Cancer-Relevant Proteins in Plasma.Advances in Proteomic Technologies and Its Contribution to the Field of CancerMass spectrometric immunoassay for quantitative determination of transthyretin and its variants.Accuracy and Reproducibility in Quantification of Plasma Protein Concentrations by Mass Spectrometry without the Use of Isotopic StandardsTotal ApoE and ApoE4 isoform assays in an Alzheimer's disease case-control study by targeted mass spectrometry (n=669): a pilot assay for methionine-containing proteotypic peptidesSerum apolipoprotein A-1 quantification by LC-MS with a SILAC internal standard reveals reduced levels in smokers.Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.Recommendations for the Generation, Quantification, Storage, and Handling of Peptides Used for Mass Spectrometry-Based AssaysMultiple-reaction monitoring-mass spectrometric assays can accurately measure the relative protein abundance in complex mixturesReplacing immunoassays with tryptic digestion-peptide immunoaffinity enrichment and LC-MS/MSTargeted quantification of low ng/mL level proteins in human serum without immunoaffinity depletionInterlaboratory reproducibility of selective reaction monitoring assays using multiple upfront analyte enrichment strategies.Rapid development of sensitive, high-throughput, quantitative and highly selective mass spectrometric targeted immunoassays for clinically important proteins in human plasma and serumIdentification and biochemical analysis of a novel APOB mutation that causes autosomal dominant hypercholesterolemia.Discrimination of ischemic and hemorrhagic strokes using a multiplexed, mass spectrometry-based assay for serum apolipoproteins coupled to multi-marker ROC algorithmTowards clinical applications of selected reaction monitoring for plasma protein biomarker studies.Mass spectrometry-based targeted quantitative proteomics: achieving sensitive and reproducible detection of proteins.The current status of clinical proteomics and the use of MRM and MRM(3) for biomarker validation.Honey protein extraction and determination by mass spectrometry.Pre-analytical and analytical variability in absolute quantitative MRM-based plasma proteomic studies.LC-MS/MS in the routine clinical laboratory: has its time come?Clinical proteomics in obstetrics and neonatology.Quantitation of human peptides and proteins via MS: review of analytically validated assays.Applications of low-flow LC-SRM for the analysis of large molecules in pharmaceutical R&D.Sample preparation strategies for targeted proteomics via proteotypic peptides in human blood using liquid chromatography tandem mass spectrometry.Mass spectrometry meets the challenge of understanding the complexity of the lipoproteome: recent findings regarding proteins involved in dyslipidemia and cardiovascular disease.Towards reproducible MRM based biomarker discovery using dried blood spots.Improved precision of proteomic measurements in immunoprecipitation based purifications using relative quantitation.First-trimester multimarker prediction of gestational diabetes mellitus using targeted mass spectrometry.
P2860
Q34197032-1A3AC8AF-BAD0-46D2-A0B2-4C60D7FA6970Q34216869-FDAA969A-B3A8-4A3E-8193-B26F7BC27F1BQ34392988-2ED54014-6875-4047-9BAE-5239DF1E2233Q34751690-460A767C-C5EA-4CC7-9CF7-25F06795685AQ34997502-B7E78EEE-8433-4C53-8003-E3F3B06940A6Q35044673-444DABC9-5E04-4748-9B2E-639F7E78D863Q35264312-F25C948A-0A51-4DCD-8221-23BBDE4BFAA9Q35598966-E060C863-3566-4D27-B209-D6946B6CD0C6Q35798915-D217D10B-C3D1-43C7-859C-567A89AB7548Q36020300-88C5D059-8749-4D83-9873-8B0422CF5D84Q36031629-47117CF8-143C-43E1-AD76-609BF9F15605Q36040373-216F7205-9954-4E20-96DF-A809C2468EBDQ36112651-A8CDCC32-5449-453F-9E50-623101F9CB14Q36142761-4393F4E8-B6B7-44BD-9A5B-0512B869391FQ36170999-CD3B2EF9-14FB-42F3-BB5B-7596A8250D6AQ36386913-F9F1A5F2-B215-49DF-908A-27F9D47050E0Q36533665-AB582C07-FD2D-4FE5-9E86-9E4F89BB4AA7Q36736452-AAE3AFC6-2061-4DE2-9DF3-A992E2798CD6Q36794987-DB955FA9-3297-4112-A53C-3139CB793596Q36881534-85D810A1-15DD-4D1B-A6AC-09D24C22EBB9Q36977460-8EE6E8EA-469D-4938-B669-D5264508A57CQ37069906-2057C347-DBF5-4C19-AA52-6326FDEC1173Q37142875-E618E48D-A0D8-4CD0-8C49-BA099229E658Q37187946-0A67DEB1-F376-4D7B-846F-66DED0218570Q37398099-F0FF9C29-C0EA-4441-9138-9B51AA0057D9Q37542168-C5F7E832-2184-4229-8E9F-B01534C5B39DQ37972865-99B07A96-352F-4D7C-B6FD-F744E4D9CF74Q38009277-9873C443-6423-4626-A2C7-8DD55930F7F7Q38012171-1FB0D4D7-D0E8-4FDA-B80E-A801DFF9904BQ38071903-3B572858-82EF-43E0-9A88-82B0D74CF474Q38164428-630EB544-2B6F-4BDF-BFB4-6F6709EFE1DAQ38171274-D87ED458-782E-4133-8095-C8278477B666Q38176934-4C8A352A-A4BC-48A7-B0A3-3F885851E84EQ38243345-651E1017-66D6-4C87-95EB-B4EA016C337DQ38243346-6A1F5529-0175-4D11-834E-5A6D40F5AFEEQ38270732-32B9E837-C409-451A-A043-0FE51E93342FQ38577853-F0ADB649-0DA3-44BF-9933-720A76B9E1FDQ38874510-C942ACD6-483C-4ADB-8C4E-B75822346A5FQ38893937-781D26ED-AC4A-4A18-9EE8-005B4DB66A7EQ38915417-8B2D28B6-67D2-4917-95B4-75991BE28076
P2860
Simultaneous quantification of apolipoprotein A-I and apolipoprotein B by liquid-chromatography-multiple- reaction-monitoring mass spectrometry
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Simultaneous quantification of ...... n-monitoring mass spectrometry
@ast
Simultaneous quantification of ...... n-monitoring mass spectrometry
@en
type
label
Simultaneous quantification of ...... n-monitoring mass spectrometry
@ast
Simultaneous quantification of ...... n-monitoring mass spectrometry
@en
prefLabel
Simultaneous quantification of ...... n-monitoring mass spectrometry
@ast
Simultaneous quantification of ...... n-monitoring mass spectrometry
@en
P2860
P1433
P1476
Simultaneous quantification of ...... n-monitoring mass spectrometry
@en
P2093
Luke C Marney
Sean A Agger
P2860
P304
P356
10.1373/CLINCHEM.2010.152264
P407
P577
2010-10-05T00:00:00Z